Market Research Report

Globaler In-vivo-CRO-MarktBericht nach Tiermodell (auf Nagetierbasis).(Rattenmodelle, Mäusemodelle, AndereNagetiermodelle), nicht auf Nagetieren basierend), nach Service(Bioanalyse und DMPK-Studien, ToxizitätStudien (GLP-Toxikologiestudien, Non-GLPToxikologische Studien), Andere Dienstleistungen), VonArzneimitteltyp (kleinmolekulare Arzneimittel, großmolekulare Arzneimittel).Medikamente (Zell- und Gentherapie,RNA-Therapie, Andere)), Von TherapeuticBereich (Onkologie, Klinische Pharmakologie, Kardiologie,Infektionskrankheiten, Neurologie, Gastroenterologie undHepatologie, Stoffwechsel und Endokrine, Ophthalmologie,Autoimmun-/Entzündungserkrankungen, Andere),Nach Endverwendung (pharmazeutisch und biopharmazeutisch).Unternehmen, Unternehmen für medizinische Geräte, Akademikerund Forschungsinstitute) und vonRegionen – Branchentrends, Größe,Anteil, Wachstum, Schätzung und Prognose,2023-2032

ID:VMR112114389
April 2024
REPORT FORMATS: ELECTRONIC (PDF), MS EXCEL

Frequently Asked Questions (FAQs) about this Report

For the year 2023, the global market size for In Vivo CRO Market was valued at USD 5.06 Billion.

The Global In Vivo CRO Market growth is estimated to be close to 8.09% between 2024 and 2032.

In the Global In Vivo CRO Market, North America holds the largest market share.

The Global In Vivo CRO Market is segmented by Animal Model (Rodent-Based (Rat Models, Mice Models, Other Rodent Models), Non-Rodent-Based), by Service (Bioanalysis & DMPK Studies, Toxicity Studies (GLP Toxicology Studies, Non-GLP Toxicology Studies), Other Services), by Drug Type (Small-Molecule Drugs, Large-Molecule Drugs (Cell & Gene Therapy, RNA Therapy, Other)), by Therapeutic Area (Oncology, Clinical Pharmacology, Cardiology, Infectious Diseases, Neurology, Gastroenterology & Hepatology, Metabolic & Endocrine, Ophthalmology, Autoimmune / Inflammatory Conditions, Other), by End-use (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Academic & Research Institutes).

The leading players in the Global In Vivo CRO Market are Biocytogen, Charles River Laboratories International Inc., Crown Bioscience, Evotec, GemPharmatech, IQVIA Inc., Icon Plc, Labcorp Drug Development, Parexel International Corporation, PsychoGenics Inc., Taconic Biosciences, Inc.
Choose your Buying Option
Buy Now
Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities
Request for Special Pricing
Objectives of Study
  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments
Why Choose Us
  • Client First Policy
  • Excellent Quality
  • After Sales Support
  • 24/7 Email Support
Testimonials

Key questions answered by the report

  • What is the current market size and trends?
  • What will be the market size during the forecast period?
  • How various market factors such as a driver, restraints, and opportunity impact the market?
  • What are the dominating segment and region in the market and why

Need specific market information?

  • Ask for free product review call with the author
  • Share your specific research requirments for a customized report
  • Request for due diligence and consumer centric studies
  • Request for study updates, segment specific and country level reports
  • Follow Us

CONTACT

BUSINESS HOURS

© , All Rights Reserved, Value Market Research